Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular eraGaurav Goyal, Eli L. Diamond, Eric D. Jacobsen et al.|Blood|2020Cited by 397
Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasmsBenjamin H. Durham, Omar Abdel‐Wahab, Estibaliz Lopez Rodrigo et al.|Nature Medicine|2019Cited by 228
Mixed histiocytic neoplasms: A multicentre series revealing diverse somatic mutations and responses to targeted therapyJoshua Friedman, Eli L. Diamond, Benjamin H. Durham et al.|British Journal of Haematology|2024Cited by 15
Mutant <i>PIK3CA</i> is a targetable driver alteration in histiocytic neoplasmsBenjamin H. Durham, Roei David Mazor|Blood Advances|2023Cited by 10